Zacks Research Has Pessimistic Opinion of THC Q4 Earnings

Tenet Healthcare Corporation (NYSE:THC) – Zacks Research cut their Q4 2027 earnings estimates for shares of Tenet Healthcare in a research note issued on Friday, October 16th. Zacks Research analyst Team now expects that the company will post earnings of $5.12 per share for the quarter, down from their previous forecast of $5.13. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Tenet Healthcare’s current full-year earnings is $21.04 per share.

A number of other equities analysts also recently issued reports on the company. UBS Group increased their price target on Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. Weiss Ratings upgraded Tenet Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $305.00 target price on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Raymond James Financial reiterated an “outperform” rating and set a $285.00 target price on shares of Tenet Healthcare in a research report on Friday, August 14th. Finally, TD Cowen lifted their price target on shares of Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Eighteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $278.45.

Tenet Healthcare Trading Up 2.2%

THC stock opened at $272.23 on Monday. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. Tenet Healthcare has a 52-week low of $157.58 and a 52-week high of $283.05. The company’s 50-day simple moving average is $264.73 and its 200-day simple moving average is $220.42. The firm has a market cap of $21.92 billion, a P/E ratio of 10.50, a PEG ratio of 1.02 and a beta of 1.20.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the business posted $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS.

Insider Transactions at Tenet Healthcare

In related news, Director Richard Mark sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the completion of the sale, the director directly owned 25,121 shares in the company, valued at approximately $6,617,373.82. The trade was a 28.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Saumya Sutaria sold 50,000 shares of the stock in a transaction on Monday, August 24th. The shares were sold at an average price of $278.71, for a total value of $13,935,500.00. Following the completion of the transaction, the chief executive officer directly owned 483,564 shares of the company’s stock, valued at approximately $134,774,122.44. This represents a 9.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 131,199 shares of company stock valued at $35,065,587. Insiders own 0.97% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

A number of hedge funds have recently modified their holdings of the business. Nisa Investment Advisors LLC boosted its stake in Tenet Healthcare by 3.3% during the third quarter. Nisa Investment Advisors LLC now owns 2,617 shares of the company’s stock worth $669,000 after buying an additional 83 shares during the period. Diversify Advisory Services LLC increased its position in shares of Tenet Healthcare by 35.7% during the third quarter. Diversify Advisory Services LLC now owns 13,617 shares of the company’s stock valued at $3,746,000 after acquiring an additional 3,584 shares during the last quarter. CWA Asset Management Group LLC raised its stake in shares of Tenet Healthcare by 8.8% in the 3rd quarter. CWA Asset Management Group LLC now owns 26,209 shares of the company’s stock valued at $6,698,000 after acquiring an additional 2,114 shares during the period. Kaufman Rossin Wealth LLC purchased a new stake in shares of Tenet Healthcare in the 3rd quarter valued at approximately $219,000. Finally, SteelPeak Wealth LLC lifted its holdings in shares of Tenet Healthcare by 6.8% in the 3rd quarter. SteelPeak Wealth LLC now owns 2,498 shares of the company’s stock worth $638,000 after acquiring an additional 159 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.